We are live on ! Find out more
BSX icon

Boston Scientific

800 hedge funds and large institutions have $41.6B invested in Boston Scientific in 2020 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 295 increasing their positions, 306 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.89% less ownership

Funds ownership: 91.99%91.11% (-0.89%)

4% less repeat investments, than reductions

Existing positions increased: 295 | Existing positions reduced: 306

6% less funds holding

Funds holding: 853800 (-53)

16% less call options, than puts

Call options by funds: $173M | Put options by funds: $206M

21% less funds holding in top 10

Funds holding in top 10: 2923 (-6)

28% less capital invested

Capital invested by funds: $58B → $41.6B (-$16.4B)

33% less first-time investments, than exits

New positions opened: 89 | Existing positions closed: 132

Holders
800
Holders Change
-53
Holders Change %
-6.21%
% of All Funds
17.63%
Holding in Top 10
23
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-20.69%
% of All Funds
0.51%
New
89
Increased
295
Reduced
306
Closed
132
Calls
$173M
Puts
$206M
Net Calls
-$33.3M
Net Calls Change
-$44.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Trading
426
Walleye Trading
New York
$815K -$2.84M -72,726 -74%
HCM
427
Hodges Capital Management
Texas
$804K -$867K -22,200 -47%
EH
428
Equitable Holdings
New York
$795K +$2.46K +63 +0.3%
IIM
429
Intact Investment Management
Quebec, Canada
$790K +$156K +4,000 +20%
PAG
430
Private Advisor Group
New Jersey
$789K -$166K -4,242 -15%
RZH
431
Relyea Zuckerberg Hanson
Connecticut
$778K
BCV
432
Banque Cantonale Vaudoise
Switzerland
$775K +$65.5K +1,676 +8%
GAM
433
Gotham Asset Management
New York
$766K +$917K +23,468 New
Cambridge Investment Research Advisors
434
Cambridge Investment Research Advisors
Iowa
$759K -$429K -10,985 -32%
GGHC
435
Gilder Gagnon Howe & Co
New York
$751K -$726K -18,589 -45%
NAM
436
Nexpoint Asset Management
Texas
$750K +$899K +23,000 New
FQ
437
First Quadrant
California
$744K -$184K -4,700 -17%
Baird Financial Group
438
Baird Financial Group
Wisconsin
$743K -$60.7K -1,553 -6%
AIP
439
Ameritas Investment Partners
Nebraska
$742K -$20.1K -515 -2%
ATC
440
Argent Trust Co
Tennessee
$731K +$2.03K +52 +0.2%
LNWWM
441
Laird Norton Wetherby Wealth Management
California
$724K -$44K -1,126 -5%
DADC
442
D.A. Davidson & Co
Montana
$719K +$83.9K +2,148 +11%
CP
443
Cumberland Partners
Ontario, Canada
$718K +$170K +4,350 +25%
Wealthfront Advisers
444
Wealthfront Advisers
California
$717K -$824K -21,087 -49%
GC
445
Grimes & Company
Massachusetts
$697K +$37.6K +963 +5%
MC
446
Moors & Cabot
Massachusetts
$674K -$420K -10,750 -34%
BF
447
BOK Financial
Oklahoma
$664K +$18.9K +484 +2%
BMO
448
Beck Mack & Oliver
New York
$656K -$70.3K -1,800 -8%
BP
449
BBR Partners
New York
$653K +$781K +20,000 New
MERSOM
450
Municipal Employees' Retirement System of Michigan
Michigan
$652K +$9.38K +240 +1%

BSX Hedge Fund Activity: Q1 2020 in Review

800 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2020, worth a combined $41.6B — down 28% from $58B a quarter earlier.

Sellers outnumbered buyers: 132 funds closed out of BSX and 89 opened new positions — a net loss of 43 holders — while 306 trimmed existing stakes and 295 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $631M. The largest seller was Capital World Investors, cutting an estimated $1.05B.

  • 800 institutional investors held Boston Scientific (BSX) as of Q1 2020, down from 853 in Q4 2019.
  • Funds reported $41.6B of Boston Scientific stock for Q1 2020, down 28% quarter-over-quarter.
  • 89 funds opened new Boston Scientific positions in Q1 2020 and 132 closed out, a net change of -43 holders.
  • The largest Boston Scientific buyer in Q1 2020 was Massachusetts Financial Services, an estimated $631M added.
  • The largest Boston Scientific seller in Q1 2020 was Capital World Investors, an estimated $1.05B sold.

Based on aggregated 13F filings for Q1 2020.